Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MO › Poplar Bluff › NPI 1972596757
Physician OIG excluded

Naushad, Abdul

Naushad, Abdul was paid $60K by Medicaid between Jan 2018 and Mar 2020, across 6 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.

33Billing provider infoNAUSHAD, ABDUL
POPLAR BLUFF, MO 63901
33aNPI1972596757assigned 08/26/2005
28Total paid$60K
24GClaims1,344
24DCodes billed6
24AFirst – last monthJan 2018 – Mar 2020
Compared with peers

Next to other Pain Medicine (Anesthesiology) Physician providers in Missouri

Rank by total paid#11 of 24
Median peer was paid$27K
This provider vs. median2.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

OIG exclusionListed on the federal exclusion list (06/20/2023).
Box 24A · Dates of service

Paid by month

$0$2.0K$4.0K$6.0K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,129$49K
2019194$11K
202021$317.80
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 38% 609 553 $23K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 25% 257 247 $15K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 22% 158 156 $14K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 10.0% 240 222 $6K
62323 3.8% 15 13 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.6% 65 65 $975.23

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.